repaglinide 1 MG Oral Tablet
1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Repaglinide tablets are a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitation of Use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( 1 )
Mylan Institutional Inc.
ROUND BLUE M R22
Related Pills
repaglinide 2 MG Oral Tablet
Mylan Institutional Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Repaglinide Tablets, USP are available containing 0.5 mg, 1 mg or 2 mg of repaglinide, USP. The 0.5 mg tablets are white to off-white, round, unscored tablets debossed with M on one side of the tablet and R21 on the other side. They are available as follows: NDC 51079-062-03 – Unit dose blister packages of 30 (3 cards of 10 tablets each). The 1 mg tablets are light blue, round, unscored tablets debossed with M on one side of the tablet and R22 on the other side. They are available as follows: NDC 51079-539-03 – Unit dose blister packages of 30 (3 cards of 10 tablets each). The 2 mg tablets are light green, round, unscored tablets debossed with M on one side of the tablet and R23 on the other side. They are available as follows: NDC 51079-555-03 – Unit dose blister packages of 30 (3 cards of 10 tablets each). Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light and moisture.
More pills like ROUND M R22